Global Specialty Generics Market Growth (Status and Outlook) 2022-2028
- LP 4857926
- 103 Pages
- February 2022
- Pharmaceuticals
The United States Specialty Generics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Specialty Generics market, reaching US$ million by the year 2028. As for the Europe Specialty Generics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Specialty Generics players cover Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., and Mallinckrodt, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Specialty Generics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Injectables
Oral
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Retail Pharmacies
Specialty Pharmacies
Hospital Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Teva Pharmaceuticals Industries
Akorn, Inc.
Mylan N.V.
Mallinckrodt
Sandoz International GmbH
Pfizer, Inc.
Sun Pharmaceutical Industries Ltd.
Valeant Pharmaceuticals
Apotex Corp.
Endo International plc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Specialty Generics Market Size 2017-2028
2.1.2 Specialty Generics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Specialty Generics Segment by Type
2.2.1 Injectables
2.2.2 Oral
2.2.3 Others
2.3 Specialty Generics Market Size by Type
2.3.1 Specialty Generics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Specialty Generics Market Size Market Share by Type (2017-2022)
2.4 Specialty Generics Segment by Application
2.4.1 Retail Pharmacies
2.4.2 Specialty Pharmacies
2.4.3 Hospital Pharmacies
2.5 Specialty Generics Market Size by Application
2.5.1 Specialty Generics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Specialty Generics Market Size Market Share by Application (2017-2022)
3 Specialty Generics Market Size by Player
3.1 Specialty Generics Market Size Market Share by Players
3.1.1 Global Specialty Generics Revenue by Players (2020-2022)
3.1.2 Global Specialty Generics Revenue Market Share by Players (2020-2022)
3.2 Global Specialty Generics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Specialty Generics by Regions
4.1 Specialty Generics Market Size by Regions (2017-2022)
4.2 Americas Specialty Generics Market Size Growth (2017-2022)
4.3 APAC Specialty Generics Market Size Growth (2017-2022)
4.4 Europe Specialty Generics Market Size Growth (2017-2022)
4.5 Middle East & Africa Specialty Generics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Specialty Generics Market Size by Country (2017-2022)
5.2 Americas Specialty Generics Market Size by Type (2017-2022)
5.3 Americas Specialty Generics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Specialty Generics Market Size by Region (2017-2022)
6.2 APAC Specialty Generics Market Size by Type (2017-2022)
6.3 APAC Specialty Generics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Specialty Generics by Country (2017-2022)
7.2 Europe Specialty Generics Market Size by Type (2017-2022)
7.3 Europe Specialty Generics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Specialty Generics by Region (2017-2022)
8.2 Middle East & Africa Specialty Generics Market Size by Type (2017-2022)
8.3 Middle East & Africa Specialty Generics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Specialty Generics Market Forecast
10.1 Global Specialty Generics Forecast by Regions (2023-2028)
10.1.1 Global Specialty Generics Forecast by Regions (2023-2028)
10.1.2 Americas Specialty Generics Forecast
10.1.3 APAC Specialty Generics Forecast
10.1.4 Europe Specialty Generics Forecast
10.1.5 Middle East & Africa Specialty Generics Forecast
10.2 Americas Specialty Generics Forecast by Country (2023-2028)
10.2.1 United States Specialty Generics Market Forecast
10.2.2 Canada Specialty Generics Market Forecast
10.2.3 Mexico Specialty Generics Market Forecast
10.2.4 Brazil Specialty Generics Market Forecast
10.3 APAC Specialty Generics Forecast by Region (2023-2028)
10.3.1 China Specialty Generics Market Forecast
10.3.2 Japan Specialty Generics Market Forecast
10.3.3 Korea Specialty Generics Market Forecast
10.3.4 Southeast Asia Specialty Generics Market Forecast
10.3.5 India Specialty Generics Market Forecast
10.3.6 Australia Specialty Generics Market Forecast
10.4 Europe Specialty Generics Forecast by Country (2023-2028)
10.4.1 Germany Specialty Generics Market Forecast
10.4.2 France Specialty Generics Market Forecast
10.4.3 UK Specialty Generics Market Forecast
10.4.4 Italy Specialty Generics Market Forecast
10.4.5 Russia Specialty Generics Market Forecast
10.5 Middle East & Africa Specialty Generics Forecast by Region (2023-2028)
10.5.1 Egypt Specialty Generics Market Forecast
10.5.2 South Africa Specialty Generics Market Forecast
10.5.3 Israel Specialty Generics Market Forecast
10.5.4 Turkey Specialty Generics Market Forecast
10.5.5 GCC Countries Specialty Generics Market Forecast
10.6 Global Specialty Generics Forecast by Type (2023-2028)
10.7 Global Specialty Generics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Teva Pharmaceuticals Industries
11.1.1 Teva Pharmaceuticals Industries Company Information
11.1.2 Teva Pharmaceuticals Industries Specialty Generics Product Offered
11.1.3 Teva Pharmaceuticals Industries Specialty Generics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Teva Pharmaceuticals Industries Main Business Overview
11.1.5 Teva Pharmaceuticals Industries Latest Developments
11.2 Akorn, Inc.
11.2.1 Akorn, Inc. Company Information
11.2.2 Akorn, Inc. Specialty Generics Product Offered
11.2.3 Akorn, Inc. Specialty Generics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Akorn, Inc. Main Business Overview
11.2.5 Akorn, Inc. Latest Developments
11.3 Mylan N.V.
11.3.1 Mylan N.V. Company Information
11.3.2 Mylan N.V. Specialty Generics Product Offered
11.3.3 Mylan N.V. Specialty Generics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Mylan N.V. Main Business Overview
11.3.5 Mylan N.V. Latest Developments
11.4 Mallinckrodt
11.4.1 Mallinckrodt Company Information
11.4.2 Mallinckrodt Specialty Generics Product Offered
11.4.3 Mallinckrodt Specialty Generics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Mallinckrodt Main Business Overview
11.4.5 Mallinckrodt Latest Developments
11.5 Sandoz International GmbH
11.5.1 Sandoz International GmbH Company Information
11.5.2 Sandoz International GmbH Specialty Generics Product Offered
11.5.3 Sandoz International GmbH Specialty Generics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Sandoz International GmbH Main Business Overview
11.5.5 Sandoz International GmbH Latest Developments
11.6 Pfizer, Inc.
11.6.1 Pfizer, Inc. Company Information
11.6.2 Pfizer, Inc. Specialty Generics Product Offered
11.6.3 Pfizer, Inc. Specialty Generics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Pfizer, Inc. Main Business Overview
11.6.5 Pfizer, Inc. Latest Developments
11.7 Sun Pharmaceutical Industries Ltd.
11.7.1 Sun Pharmaceutical Industries Ltd. Company Information
11.7.2 Sun Pharmaceutical Industries Ltd. Specialty Generics Product Offered
11.7.3 Sun Pharmaceutical Industries Ltd. Specialty Generics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sun Pharmaceutical Industries Ltd. Main Business Overview
11.7.5 Sun Pharmaceutical Industries Ltd. Latest Developments
11.8 Valeant Pharmaceuticals
11.8.1 Valeant Pharmaceuticals Company Information
11.8.2 Valeant Pharmaceuticals Specialty Generics Product Offered
11.8.3 Valeant Pharmaceuticals Specialty Generics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Valeant Pharmaceuticals Main Business Overview
11.8.5 Valeant Pharmaceuticals Latest Developments
11.9 Apotex Corp.
11.9.1 Apotex Corp. Company Information
11.9.2 Apotex Corp. Specialty Generics Product Offered
11.9.3 Apotex Corp. Specialty Generics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Apotex Corp. Main Business Overview
11.9.5 Apotex Corp. Latest Developments
11.10 Endo International plc.
11.10.1 Endo International plc. Company Information
11.10.2 Endo International plc. Specialty Generics Product Offered
11.10.3 Endo International plc. Specialty Generics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Endo International plc. Main Business Overview
11.10.5 Endo International plc. Latest Developments
12 Research Findings and Conclusion
Table 1. Specialty Generics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Injectables
Table 3. Major Players of Oral
Table 4. Major Players of Others
Table 5. Specialty Generics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Specialty Generics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Specialty Generics Market Size Market Share by Type (2017-2022)
Table 8. Specialty Generics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Specialty Generics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Specialty Generics Market Size Market Share by Application (2017-2022)
Table 11. Global Specialty Generics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Specialty Generics Revenue Market Share by Player (2020-2022)
Table 13. Specialty Generics Key Players Head office and Products Offered
Table 14. Specialty Generics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Specialty Generics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Specialty Generics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Specialty Generics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Specialty Generics Market Size Market Share by Country (2017-2022)
Table 21. Americas Specialty Generics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Specialty Generics Market Size Market Share by Type (2017-2022)
Table 23. Americas Specialty Generics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Specialty Generics Market Size Market Share by Application (2017-2022)
Table 25. APAC Specialty Generics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Specialty Generics Market Size Market Share by Region (2017-2022)
Table 27. APAC Specialty Generics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Specialty Generics Market Size Market Share by Type (2017-2022)
Table 29. APAC Specialty Generics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Specialty Generics Market Size Market Share by Application (2017-2022)
Table 31. Europe Specialty Generics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Specialty Generics Market Size Market Share by Country (2017-2022)
Table 33. Europe Specialty Generics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Specialty Generics Market Size Market Share by Type (2017-2022)
Table 35. Europe Specialty Generics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Specialty Generics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Specialty Generics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Specialty Generics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Specialty Generics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Specialty Generics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Specialty Generics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Specialty Generics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Specialty Generics
Table 44. Key Market Challenges & Risks of Specialty Generics
Table 45. Key Industry Trends of Specialty Generics
Table 46. Global Specialty Generics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Specialty Generics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Specialty Generics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Specialty Generics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Specialty Generics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Specialty Generics Market Size Market Share Forecast by Application (2023-2028)
Table 52. Teva Pharmaceuticals Industries Details, Company Type, Specialty Generics Area Served and Its Competitors
Table 53. Teva Pharmaceuticals Industries Specialty Generics Product Offered
Table 54. Teva Pharmaceuticals Industries Specialty Generics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Teva Pharmaceuticals Industries Main Business
Table 56. Teva Pharmaceuticals Industries Latest Developments
Table 57. Akorn, Inc. Details, Company Type, Specialty Generics Area Served and Its Competitors
Table 58. Akorn, Inc. Specialty Generics Product Offered
Table 59. Akorn, Inc. Main Business
Table 60. Akorn, Inc. Specialty Generics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Akorn, Inc. Latest Developments
Table 62. Mylan N.V. Details, Company Type, Specialty Generics Area Served and Its Competitors
Table 63. Mylan N.V. Specialty Generics Product Offered
Table 64. Mylan N.V. Main Business
Table 65. Mylan N.V. Specialty Generics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Mylan N.V. Latest Developments
Table 67. Mallinckrodt Details, Company Type, Specialty Generics Area Served and Its Competitors
Table 68. Mallinckrodt Specialty Generics Product Offered
Table 69. Mallinckrodt Main Business
Table 70. Mallinckrodt Specialty Generics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Mallinckrodt Latest Developments
Table 72. Sandoz International GmbH Details, Company Type, Specialty Generics Area Served and Its Competitors
Table 73. Sandoz International GmbH Specialty Generics Product Offered
Table 74. Sandoz International GmbH Main Business
Table 75. Sandoz International GmbH Specialty Generics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Sandoz International GmbH Latest Developments
Table 77. Pfizer, Inc. Details, Company Type, Specialty Generics Area Served and Its Competitors
Table 78. Pfizer, Inc. Specialty Generics Product Offered
Table 79. Pfizer, Inc. Main Business
Table 80. Pfizer, Inc. Specialty Generics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Pfizer, Inc. Latest Developments
Table 82. Sun Pharmaceutical Industries Ltd. Details, Company Type, Specialty Generics Area Served and Its Competitors
Table 83. Sun Pharmaceutical Industries Ltd. Specialty Generics Product Offered
Table 84. Sun Pharmaceutical Industries Ltd. Main Business
Table 85. Sun Pharmaceutical Industries Ltd. Specialty Generics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Sun Pharmaceutical Industries Ltd. Latest Developments
Table 87. Valeant Pharmaceuticals Details, Company Type, Specialty Generics Area Served and Its Competitors
Table 88. Valeant Pharmaceuticals Specialty Generics Product Offered
Table 89. Valeant Pharmaceuticals Main Business
Table 90. Valeant Pharmaceuticals Specialty Generics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Valeant Pharmaceuticals Latest Developments
Table 92. Apotex Corp. Details, Company Type, Specialty Generics Area Served and Its Competitors
Table 93. Apotex Corp. Specialty Generics Product Offered
Table 94. Apotex Corp. Main Business
Table 95. Apotex Corp. Specialty Generics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Apotex Corp. Latest Developments
Table 97. Endo International plc. Details, Company Type, Specialty Generics Area Served and Its Competitors
Table 98. Endo International plc. Specialty Generics Product Offered
Table 99. Endo International plc. Main Business
Table 100. Endo International plc. Specialty Generics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Endo International plc. Latest Developments
List of Figures
Figure 1. Specialty Generics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Specialty Generics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Specialty Generics Market Size Market Share by Type in 2021
Figure 7. Specialty Generics in Retail Pharmacies
Figure 8. Global Specialty Generics Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 9. Specialty Generics in Specialty Pharmacies
Figure 10. Global Specialty Generics Market: Specialty Pharmacies (2017-2022) & ($ Millions)
Figure 11. Specialty Generics in Hospital Pharmacies
Figure 12. Global Specialty Generics Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 13. Global Specialty Generics Market Size Market Share by Application in 2021
Figure 14. Global Specialty Generics Revenue Market Share by Player in 2021
Figure 15. Global Specialty Generics Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Specialty Generics Market Size 2017-2022 ($ Millions)
Figure 17. APAC Specialty Generics Market Size 2017-2022 ($ Millions)
Figure 18. Europe Specialty Generics Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Specialty Generics Market Size 2017-2022 ($ Millions)
Figure 20. Americas Specialty Generics Value Market Share by Country in 2021
Figure 21. Americas Specialty Generics Consumption Market Share by Type in 2021
Figure 22. Americas Specialty Generics Market Size Market Share by Application in 2021
Figure 23. United States Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Specialty Generics Market Size Market Share by Region in 2021
Figure 28. APAC Specialty Generics Market Size Market Share by Application in 2021
Figure 29. China Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Specialty Generics Market Size Market Share by Country in 2021
Figure 36. Europe Specialty Generics Market Size Market Share by Type in 2021
Figure 37. Europe Specialty Generics Market Size Market Share by Application in 2021
Figure 38. Germany Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Specialty Generics Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Specialty Generics Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Specialty Generics Market Size Market Share by Application in 2021
Figure 46. Egypt Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Specialty Generics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 52. APAC Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 53. Europe Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 55. United States Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 56. Canada Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 59. China Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 60. Japan Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 61. Korea Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 63. India Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 64. Australia Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 65. Germany Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 66. France Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 67. UK Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 68. Italy Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 69. Russia Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 70. Spain Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 73. Israel Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Specialty Generics Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Specialty Generics Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
